IDH1 and central nervous system cancer: While their analyses did not provide specific P values, they identified two CpGs within the PD‐L1 promoter (cg15837913 and cg19724470) that exhibited differential methylation patterns between normal brains and tumors as well as IDH‐mutant and wildtype gliomas.